ArkeaBio™ Raises $26.5M to Reduce Greenhouse Gas Emissions with Methane Vaccine
ArkeaBio™, a leading ag-biotech start-up developing a vaccine to reduce livestock methane emissions, today announced the close of a $26.5 million Series A financing round.
- ArkeaBio™, a leading ag-biotech start-up developing a vaccine to reduce livestock methane emissions, today announced the close of a $26.5 million Series A financing round.
- ArkeaBio’s vaccine will provide an innovative, cost-effective, and scalable solution to reduce the world’s livestock methane emissions, which currently generate the equivalent of 3 Billion Tonnes of CO2 annually and represent 6% of annual Greenhouse gas emissions.
- New technologies can help to prevent accelerating methane emissions from the agricultural sector.
- “A methane vaccine for ruminant animals is internationally recognised as the ‘holy grail’ to deliver methane reduction at low cost and mass scale.